Search results
Results from the WOW.Com Content Network
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [ 10 ] [ 11 ] [ 12 ] Specifically it is used to prevent rather than treat asthma attacks. [ 10 ]
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]
The most common side effects include worsening of asthma and nasopharyngitis (inflammation in the nose and throat). [2] Other common side effects include upper respiratory tract infection (nose and throat infections) and headache. [ 2 ]
The methasones (or metasones) are a class of corticosteroids [1] which are generally used in dermatology.They are defined by substitution with a methyl group at the C16α or C16β position of the pregnane steroid nucleus.
2-Furoyl chloride is an acyl chloride of furan.It takes the form of a corrosive liquid, which is more irritating to the eyes than benzoyl chloride. [1] 2-Furoyl chloride is a useful pharmaceutical intermediate and is used in the synthesis of mometasone furoate, an antiinflammatory prodrug used in the treatment of skin disorders, hay fever and asthma.
ATC code D07 Corticosteroids, dermatological preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
Indacaterol is a long-acting beta-2 adrenergic receptor agonist. [7] It relaxes the muscle around the airways into the lungs by activating targets called beta-2 receptors in the muscle cells. [7] This helps to keep the airways open. [7] Glycopyrronium bromide is a muscarinic receptor antagonist. [7]
[1] [4] [5] It contains olopatadine hydrochloride and mometasone furoate monohydrate. [1] [4] It is sprayed into the nose. [1] [4] Common side effects include an unpleasant taste . [1] It was approved for medical use in Australia in December 2019, [1] [6] and in the United States in January 2022. [4]